arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Core Scientific, Inc./tx

CORZ
$21.01 ▼ -0.04 (-0.19%) at close
Financials ·Finance Services ·USFinance Services
24 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
46
Health
Weak
Neutral
auto_awesome

Analytical Summary

Core Scientific, Inc./tx shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Financials sector before making investment decisions.

Market Cap $6.8B
Dividend Yield
Revenue Growth 108.8%
Op. Margin -47.8%
ROIC -4.2%
FCF / Share $-1.79
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -1.78
info Valuation on last close. End-of-day price, Aug 7, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$164.20M
↑ +108.8%
Net Income Profit after all expenses
$-1.16B
↓ -23.3%
Operating Margin Operating profit as % of sales
-47.8%
↑ +82.3% 3th
FCF / Share Free cash flow per share
$-1.79
↓ -554.0%
Long-Term Debt Long-term obligations
$4.30B
↑ +304.8%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
3
Returns
93
Financial Health
26
Cash Quality
81

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 24 quarters